|
|
Taiwan Academic Institutional Repository >
Browse by Author
|
"chiu cf"
Showing items 11-35 of 109 (5 Page(s) Totally)
1 2 3 4 5 > >>
View [10|25|50] records per page
| 國家衛生研究院 |
2022-02-01 |
A prospective phase II study of biweekly S-1, leucovorin and gemcitabine in elderly patients with locally advanced or metastatic pancreatic adenocarcinoma
|
Bai, LY;Li, CP;Shan, YS;Chuang, SC;Chen, JS;Chiang, NJ;Chen, YY;Tsou, HH;Chuang, MH;Chiu, CF;Liu, TW;Chen, LT |
| 國家衛生研究院 |
2022-02 |
Phase 1 study of nanoliposomal irinotecan in combination with trifluridine/tipiracil in refractory solid tumors
|
Bai, LY;Chiang, NJ;Hsu, CH;Liang, YH;Chiu, CF;Lin, CC;Chang, KY;Chen, SH;Tsai, HJ;Lin, YP;Chen, LT;Lin, CC |
| 中山醫學大學 |
2021 |
Epidermal growth factor receptors siRNA-conjugated collagen modified gold nanoparticles for targeted imaging and therapy of lung cancer
|
Yu, AYH; Fu, RH; Hsu, SH; Chiu, CF; Fang, WH; Yeh, CA; Tang, CM; Hsieh, HH; Hung, HS |
| 中山醫學大學 |
2021 |
Delivery Capacity and Anticancer Ability of the Berberine-Loaded Gold Nanoparticles to Promote the Apoptosis Effect in Breast Cancer
|
Chiu, CF; Fu, RH; Hsu, SH; Yu, YH; Yang, SF; Tsao, TCY; Chang, KB; Yeh, CA; Tang, CM; Huang, SC; Hung, HS |
| 國家衛生研究院 |
2020-12-29 |
Modified gemcitabine, S-1, and leucovorin combination for patients with newly diagnosed locally advanced or metastatic pancreatic adenocarcinoma: A multi-center retrospective study in Taiwan
|
Chen, CY;Liang, SH;Su, YY;Chiang, NJ;Wang, HC;Chiu, CF;Chen, LT;Bai, LY |
| 國家衛生研究院 |
2019-12-01 |
Liposomal irinotecan in metastatic pancreatic adenocarcinoma in Asian patients: Subgroup analysis of the NAPOLI-1 study
|
Bang, YJ;Li, CP;Lee, KH;Chiu, CF;Park, JO;Shan, YS;Kim, JS;Chen, JS;Shim, HJ;Rau, KM;Choi, HJ;Oh, DY;Belanger, B;Chen, LT |
| 國家衛生研究院 |
2019-11-14 |
A multicenter prospective study of first-line antibiotic therapy for early-stage gastric mucosa-associated lymphoid tissue lymphoma and diffuse large B-cell lymphoma with histological evidence of mucosa-associated lymphoid tissue
|
Tsai, HJ;Tai, JJ;Chen, LT;Wu, MS;Yeh, KH;Lin, CW;Wang, TE;Wang, HP;Yu, FJ;Liou, JM;Hsiao, CF;Cheng, TY;Yeh, HJ;Ko, CW;Chen, MJ;Lo, GH;Hsu, PI;Chang, CS;Hwang, WS;Chuang, SS;Lee, HW;Shun, CT;Chiu, CF;Wang, WM;Hsieh, CY;Liu, TW;Lin, JT;Kuo, SH;Cheng, AL |
| 國家衛生研究院 |
2019-05 |
Oral paclitaxel in the treatment of metastatic breast cancer (MBC) patients
|
Dai, MS;Chao, TC;Chiu, CF;Lu, YS;Shiah, HS;Wu, YY;Cheng, WH;Chan, WK;Hung, T;Hung, N;Cutler, D;Kwan, R;Kramer, D;Chao, TY |
| 國立交通大學 |
2019-04-02T06:00:26Z |
The design of rotation-invariant pattern recognition using the silicon retina
|
Chiu, CF; Wu, CY |
| 國家衛生研究院 |
2019-03 |
Pharmacokinetic study of amoxicillin in Japanese eel Anguilla japonica by high performance liquid chromatography with fluorescence detection
|
Hung, YW;Lin, YH;Chan, CY;Wang, WS;Chiu, CF;Chiu, CC;Chiu, HW;Tsai, WH;Hung, SW |
| 國家衛生研究院 |
2019-01-18 |
TARBP2-mediated destabilization of Nanog overcomes sorafenib resistance in hepatocellular carcinoma
|
Lai, HH;Li, CW;Hong, CC;Sun, HY;Chiu, CF;Ou, DL;Chen, PS |
| 國家衛生研究院 |
2019-01-12 |
Sequential therapy of neoadjuvant biochemotherapy with cetuximab, paclitaxel, and cisplatin followed by cetuximab-based concurrent bioradiotherapy in high-risk locally advanced oral squamous cell carcinoma: Final analysis of a phase 2 clinical trial
|
Yen, CJ;Tsou, HH;Hsieh, CY;Chu, CY;Chiu, CF;Chen, CC;Tsao, CJ;Tsai, KY;Tsai, ST;Chang, JY;Chang, KY |
| 國家衛生研究院 |
2018-12 |
FOXO3a-driven alternation of metabolism dictates the gemcitabine sensitivity
|
Chiu, CF;Hung, SW;Chiu, CC;Chen, LT |
| 國家衛生研究院 |
2018-11-07 |
Survival with nal-IRI (liposomal irinotecan) plus 5-fluorouracil and leucovorin versus 5-fluorouracil and leucovorin in per-protocol and non-per-protocol populations of NAPOLI-1: Expanded analysis of a global phase 3 trial
|
Chen, LT;Siveke, JT;Wang-Gillam, A;Li, CP;Bodoky, G;Dean, AP;Shan, YS;Jameson, GS;Macarulla, T;Lee, KH;Cunningham, D;Blanc, JF;Chiu, CF;Schwartsmann, G;Braiteh, FS;Mamlouk, K;Belanger, B;de Jong, FA;Hubner, RA |
| 國家衛生研究院 |
2018-10-01 |
Pharmacokinetic study of florfenicol in Bester sturgeon, a cultured hybrid of Huso huso × Acipenser ruthenus by high performance liquid chromatography equipped with UV detector
|
Hung, YW;Lin, YH;Chen, MH;Wang, WS;Chiu, CF;Chiu, CC;Chiu, HW;Tsai, WH;Hung, SW |
| 國家衛生研究院 |
2018-02 |
HIF-1alpha promotes autophagic proteolysis of Dicer and enhances tumor metastasis
|
Lai, HH;Li, JN;Wang, MY;Huang, HY;Croce, CM;Sun, HL;Lyu, YJ;Kang, JW;Chiu, CF;Hung, MC;Suzuki, HI;Chen, PS |
| 國家衛生研究院 |
2018-02 |
Subgroup analysis by baseline (BL) weight-associated parameters: A phase III study of liposomal irinotecan (nal-IRI)+/--5fluorouracil/leucovorin (5-FU/LV) in patients (pts) with metastatic pancreatic ductal adenocarcinoma (mPDAC) previously treated with g
|
Macarulla, TM;Hubner, R;Blanc, JF;Wang-Gillam, A;Li, CP;Bodoky, G;Dean, AP;Yanshen, S;Jameson, GS;Lee, KH;Chiu, CF;Schwartsmann, G;Braiteh, FS;Cunningham, D;Chen, LT;Von Hoff, DD;Mamlouk, KK;de Jong, FA;Siveke, JT |
| 國家衛生研究院 |
2018-01 |
Epigenetic regulation of LDHA dictates the gemcitabine resistance in pancreatic cancer
|
Chiu, CF |
| 國家衛生研究院 |
2017-11 |
Subgroup analysis by prior non-liposomal irinotecan therapy in NAPOLI-1: A phase 3 study of nal-IRI65-fluorouracil/leucovorin in patients with metastatic pancreatic ductal adenocarcinoma previously treated with gemcitabine-based therapy
|
Blanc, JF;Hubner, R;Li, CP;Wang-Gillam, A;Bodoky, G;Dean, A;Shan, YS;Jameson, G;Mercade, TM;Lee, KH;Cunningham, D;Chiu, CF;Schwartsmann, G;Braiteh, F;von Hoff, D;Chen, LT;Mamlouk, K;de Jong, F;Siveke, J |
| 國家衛生研究院 |
2017-11 |
CA19-9 decrease and overall survival (OS) in the NAPOLI-1 trial of liposomal irinotecan (nal-IRI) � 5-fluorouracil and leucovorin (5-FU/LV) in metastatic pancreatic ductal adenocarcinoma (mPDAC) previously treated with gemcitabine-based therapy
|
Chen, LT;Wang-Gillam, A;Shan, YS;Mercade, TM;Blanc, JF;Hubner, R;Chiu, CF;Schwartsmann, G;Siveke, J;Belanger, B;de Jong, F;Mamlouk, K;von Hoff, D |
| 國家衛生研究院 |
2017-07 |
Terminally Ill Taiwanese cancer patients’ and family caregivers’ agreement on patterns of life-sustaining treatment preferences is poor to fair and declines over a decade: Results from two independent cross-sectional studies
|
Liu, TW;Wen, FH;Wang, CH;Hong, RL;Chow, JM;Chen, JS;Chiu, CF;Tang, ST |
| 國家衛生研究院 |
2017-06-26 |
Subgroup analysis by prior non-liposomal irinotecan therapy in NAPOLI-1: A phase 3 study of nal-IRI +/- 5-fluorouracil/leucovorin in patients with metastatic pancreatic ductal adenocarcinoma previously treated with gemcitabine-based therapy
|
Jean-Frederic, B;Richard, H;Li, CP;Andrea, WG;Gyorgy, B;Andrew, D;Shan, YS;Gayle, J;Teresa, M;Lee, H;David, C;Chiu, CF;Gilberto, S;Fadi, B;Daniel, V;Chen, LT;Khalid, M;Parul, B;Floris, D;Jens, S |
| 國家衛生研究院 |
2017-06-26 |
CA19-9 decrease and overall survival (OS) in the NAPOLI-1 trial of liposomal irinotecan (nal-IRI) +/- 5-fluorouracil and leucovorin (5FU/LV) in metastatic pancreatic ductal adenocarcinoma (mPDAC) previously treated with gemcitabine-based therapy
|
Chen, LT;Andrea, WG;Shan, YS;Teresa, M;Jean-Frederic, B;Richard, H;Chiu, CF;Gilberto, S;Jens, S;Marc, PJ;Bruce, B;Floris, D;Khalid, M;Daniel, V |
| 國家衛生研究院 |
2017-02-03 |
E1A-mediated inhibition of HSPA5 suppresses cell migration and invasion in triple-negative breast cancer [Erratum: Annals of Surgical Oncology. 2015;22(3):889-898.]
|
Chen, HA;Chang, YW;Tseng, CF;Chiu, CF;Hong, CC;Wang, W;Wang, MY;Hsiao, M;Ma, JT;Chen, CH;Jiang, SS;Wu, CH;Hung, MC;Huang, MT;Su, JL |
| 國家衛生研究院 |
2017-02 |
Efficacy and safety of liposomal irinotecan (nal-IRI)+5-fluorouracil and leucovorin (5-FU/LV) in patients (pts) with metastatic pancreatic ductal adenocarcinoma (mPDAC) who previously received gemcitabine (gem)-based therapy: Post-hoc analysis of the NAPO
|
Chen, LT;Wang-Gillam, A;Yanshen, S;Macarulla, T;Blanc, JF;Hubner, R;Chiu, CF;Schwartsmann, G;Siveke, JT;Pipas, JM;Belanger, B;de Jong, F;Mamlouk, K;Von Hoff, DD |
Showing items 11-35 of 109 (5 Page(s) Totally)
1 2 3 4 5 > >>
View [10|25|50] records per page
|
